BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22758374)

  • 1. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
    Izadi M; Fazel M; Saadat SH; Taheri S
    J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD20 antigen expression by lymphoma cells in lung allograft recipients is associated with higher remission rate and superior survival: a study on heart and lung transplant recipients.
    Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):29-37. PubMed ID: 24434379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD20+ B-cell infiltration is related to the time after transplant and poor prognosis of acute cellular rejection in renal transplant.
    Jiqiu W; Jinsong C; Dongrui C; Mingchao Z; Shuming J; Zhi-Hong L
    Exp Clin Transplant; 2013 Oct; 11(5):412-7. PubMed ID: 23428174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
    Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
    Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
    Khedmat H; Taheri S
    Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
    Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
    Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of CD20 expression by lymphoproliferative lesions developing after liver transplantation: post-transplant lymphoproliferative disorders international survey.
    Khedmat H; Ghamar-Chehreh ME; Amini M
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1293-300. PubMed ID: 25394454
    [No Abstract]   [Full Text] [Related]  

  • 19. More benign lymphoproliferative disease after liver transplant in infants.
    Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
    Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
    Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
    Hematol Oncol Stem Cell Ther; 2011; 4(4):167-72. PubMed ID: 22198192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.